Literature DB >> 7624037

Nanomolar concentrations of nicotine increase the release of [3H]dopamine from rat striatal synaptosomes.

P P Rowell1.   

Abstract

Nicotine stimulates the release of several neurotransmitters from brain tissue by acting on presynaptic nicotinic acetylcholine receptors (nAChR). In this study, an in vitro superfusion system was used to measure the nicotine-evoked release of [3H]dopamine (DA) from rat striatal synaptosomes. A 2-min exposure to micromolar nicotine produces a rapid increase in [3H]DA release. With continued exposure the response declines, apparently due to conversion of the nAChRs to a high-affinity desensitized conformation. In contrast, prolonged exposure to nanomolar concentrations of nicotine, while not producing an immediate response, leads to a gradual cumulative enhancement in [3H]DA release. This effect is calcium-dependent and blocked by the nicotinic antagonist, dihydro-beta-erythroidine. It is suggested that the gradual DA release in response to low concentrations of nicotine occurs as a result of either open channel properties of the desensitized receptor or an equilibrium between the high-affinity desensitized and active states of the nAChRs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624037     DOI: 10.1016/0304-3940(95)11471-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function.

Authors:  E Shearman; S Rossi; H Sershen; A Hashim; A Lajtha
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Endogenous opioids suppress activation of nociceptors by sub-nanomolar nicotine.

Authors:  F J Miao; N L Benowitz; J D Levine
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.

Authors:  Sanna Janhunen; Paula Mielikäinen; Päivi Paldánius; Raimo K Tuominen; Liisa Ahtee; Seppo Kaakkola
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

Review 4.  Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.

Authors:  Alvin V Terry; Caterina M Hernandez; Elizabeth J Hohnadel; Kristy P Bouchard; Jerry J Buccafusco
Journal:  CNS Drug Rev       Date:  2005

5.  Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.

Authors:  Julian R A Wooltorton; Volodymyr I Pidoplichko; Ron S Broide; John A Dani
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

6.  Airway-related vagal preganglionic neurons express multiple nicotinic acetylcholine receptor subunits.

Authors:  Ozra Dehkordi; Prabha Kc; Kannan V Balan; Musa A Haxhiu
Journal:  Auton Neurosci       Date:  2006-04-17       Impact factor: 3.145

7.  Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors.

Authors:  Katsuya Suemaru; Kayo Yasuda; Kenta Umeda; Hiroaki Araki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

8.  Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats.

Authors:  M L Gregório; E C Wietzikoski; M M Ferro; J L M Silveira; M A B F Vital; C Da Cunha
Journal:  Neurotox Res       Date:  2009-03-18       Impact factor: 3.911

9.  Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction.

Authors:  Volodymyr I Pidoplichko; Jun Noguchi; Oluwasanmi O Areola; Yong Liang; Jayms Peterson; Tianxiang Zhang; John A Dani
Journal:  Learn Mem       Date:  2004 Jan-Feb       Impact factor: 2.460

10.  Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.

Authors:  Davide Quarta; Christopher G Naylor; Jacques Barik; Cathy Fernandes; Susan Wonnacott; Ian P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2008-08-30       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.